{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:48:43Z","timestamp":1794534523219,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Gioja Bianca Costanza Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1245\/s10434-020-09467-6","type":"journal-article","created":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T13:02:32Z","timestamp":1609678952000},"page":"4602-4612","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma"],"prefix":"10.1245","volume":"28","author":[{"given":"Stefano","family":"Crippa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Giannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Schiavo Lena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Belfiori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Partelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Tamburrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Delpini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Pagnanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolo","family":"Pecorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpaolo","family":"Balzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Doglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Falconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,3]]},"reference":[{"key":"9467_CR1","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913\u201321.","journal-title":"Cancer Res."},{"key":"9467_CR2","unstructured":"ECIS: European Cancer Information System, 2020. Retrieved 12 October 2019 at https:\/\/ecis.jrc.ec.europa.eu."},{"key":"9467_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7\u201334.","journal-title":"CA Cancer J Clin."},{"key":"9467_CR4","doi-asserted-by":"publisher","first-page":"e76052","DOI":"10.1371\/journal.pone.0076052","volume":"8","author":"J Luo","year":"2013","unstructured":"Luo J, Xiao L, Wu C, Zheng Y, Zhao N. The incidence and survival rate of population-based pancreatic cancer patients: Shanghai Cancer Registry 2004\u20132009. PLoS One. 2013;8:e76052.","journal-title":"PLoS One."},{"key":"9467_CR5","unstructured":"American Cancer Society. Key Statistics for Pancreatic Cancer. Retrieved xxxx at https:\/\/www.cancer.org\/cancer\/pancreatic-cancer. Accessed 10 September 2020."},{"key":"9467_CR6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","volume":"378","author":"A Vincent","year":"2011","unstructured":"Vincent A, Herman J, Schulick R, Hruban RHGM. Pancreatic cancer. Lancet. 2011;378:607\u201320.","journal-title":"Lancet."},{"key":"9467_CR7","doi-asserted-by":"publisher","first-page":"e476","DOI":"10.1016\/S1470-2045(13)70172-4","volume":"14","author":"W Hartwig","year":"2013","unstructured":"Hartwig W, Werner J, J\u00e4ger D, Debus J, B\u00fcchler MW. Improvement of surgical results for pancreatic cancer. Lancet Oncol. 2013;14:e476\u201385.","journal-title":"Lancet Oncol."},{"key":"9467_CR8","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1002\/bjs.5397","volume":"93","author":"CS Verbeke","year":"2006","unstructured":"Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A. Redefining the R1 resection in pancreatic cancer. Br J Surg. 2006;93:1232\u20137.","journal-title":"Br J Surg."},{"key":"9467_CR9","unstructured":"Campbell F, Cairns A, Duthie F, Feakins R. Dataset for the histopathological reporting of carcinomas of the pancreas, ampulla of Vater, and common bile duct. R Coll Pathol. 2017. https:\/\/www.rcpath.org\/uploads\/assets\/34910231-c106-4629-a2de9e9ae6f87ac1\/g091-pancreasdataset-mar17.pdf."},{"key":"9467_CR10","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.surg.2014.02.001","volume":"155","author":"M Bockhorn","year":"2014","unstructured":"Bockhorn M, Uzunoglu FG, Adham M, Imrie C, Milicevic M, Sandberg AA, et al. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2014;155:977\u201388.","journal-title":"Surgery."},{"key":"9467_CR11","unstructured":"Amin MB. AJCC Cancer Staging System, 8th Edition. Am Jt Commitee Cancer. 2017."},{"key":"9467_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/hpb.12061","volume":"16","author":"JR Delpero","year":"2014","unstructured":"Delpero JR, Bachellier P, Regenet N, Le Treut YP, Paye F, Carrere N, et al. Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens. HPB. 2014;16:20\u201333.","journal-title":"HPB."},{"key":"9467_CR13","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1002\/bjs.9892","volume":"102","author":"MD Chandrasegaram","year":"2015","unstructured":"Chandrasegaram MD, Goldstein D, Simes J, Gebski V, Kench JG, Gill AJ, et al. Meta-analysis of radical resection rates and margin assessment in pancreatic cancer. Br J Surg. 2015;102:1459\u201372.","journal-title":"Br J Surg."},{"key":"9467_CR14","doi-asserted-by":"publisher","first-page":"824","DOI":"10.4143\/crt.2016.336","volume":"49","author":"KS Kim","year":"2017","unstructured":"Kim KS, Kwon J, Kim K, Chie EK. Impact of resection margin distance on survival of pancreatic cancer: a systematic review and meta-analysis. Cancer Res Treat. 2017;49:824\u201333.","journal-title":"Cancer Res Treat."},{"key":"9467_CR15","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1097\/SLA.0000000000002345","volume":"268","author":"IE Demir","year":"2018","unstructured":"Demir IE, J\u00e4ger C, Schlitter MM, Konukiewitz B, Stecher L, Schorn S, et al. R0 versus R1 resection matters after pancreaticoduodenectomy, and less after distal or total pancreatectomy for pancreatic cancer. Ann Surg. 2018;268:1058\u201368.","journal-title":"Ann Surg."},{"key":"9467_CR16","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/SLA.0000000000002557","volume":"269","author":"P Ghaneh","year":"2019","unstructured":"Ghaneh P, Kleeff J, Halloran CM, Raraty M, Jackson R, Melling J, et al. The impact of positive resection margins on survival and recurrence following resection and adjuvant chemotherapy for pancreatic ductal adenocarcinoma. Ann Surg. 2019;269:520\u20139.","journal-title":"Ann Surg."},{"key":"9467_CR17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/SLA.0000000000001731","volume":"265","author":"O Strobel","year":"2017","unstructured":"Strobel O, Hank T, Hinz U, Bergmann F, Schneider L, Springfeld C, et al. Pancreatic cancer surgery: the new R status counts. Ann Surg. 2017;265:565\u201373.","journal-title":"Ann Surg."},{"key":"9467_CR18","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1097\/SLA.0b013e3181d77369","volume":"251","author":"NB Jamieson","year":"2010","unstructured":"Jamieson NB, Foulis AK, Oien KA, Going JJ, Glen P, Dickson EJ, et al. Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma. Ann Surg. 2010;251:1003\u201310.","journal-title":"Ann Surg."},{"key":"9467_CR19","doi-asserted-by":"crossref","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453\u20137.","DOI":"10.1016\/S0140-6736(07)61602-X"},{"key":"9467_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, De Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187\u201396.","journal-title":"Ann Surg."},{"key":"9467_CR21","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jamcollsurg.2009.10.019","volume":"210","author":"J Weitz","year":"2010","unstructured":"Weitz J, Rahbari N, Koch M, B\u00fcchler MW. The \u201cartery first\u201d approach for resection of pancreatic head cancer. J Am Coll Surg. 2010;210:e1-4.","journal-title":"J Am Coll Surg."},{"key":"9467_CR22","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1245\/s10434-017-5864-9","volume":"24","author":"M Dal Molin","year":"2017","unstructured":"Dal Molin M, Blackford AL, Siddiqui A, Brant A, Cho C, Rezaee N, et al. Duodenal involvement is an independent prognostic factor for patients with surgically resected pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2017;24:2379\u201386.","journal-title":"Ann Surg Oncol."},{"key":"9467_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4174\/astr.2019.96.1.19","volume":"96","author":"Y You","year":"2019","unstructured":"You Y, Choi DW, Heo JS, Han IW, Choi SH, Jang KT, et al. Clinical significance of revised microscopic positive resection margin status in ductal adenocarcinoma of pancreatic head. Ann Surg Treat Res. 2019;96:19\u201326.","journal-title":"Ann Surg Treat Res."},{"key":"9467_CR24","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1097\/00000658-200112000-00007","volume":"234","author":"JP Neoptolemos","year":"2001","unstructured":"Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger HG, Pederzoli P, et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and\/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg. 2001;234:758\u201368.","journal-title":"Ann Surg."},{"key":"9467_CR25","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/bjs.11115","volume":"106","author":"WS Tummers","year":"2019","unstructured":"Tummers WS, Groen JV, Sibinga Mulder BG, Farina-Sarasqueta A, Morreau J, Putter H, et al. Impact of resection margin status on recurrence and survival in pancreatic cancer surgery. Br J Surg. 2019;106:1055\u201365.","journal-title":"Br J Surg."},{"key":"9467_CR26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/SLA.0b013e31821fd334","volume":"254","author":"W Hartwig","year":"2011","unstructured":"Hartwig W, Hackert T, Hinz U, Gluth A, Bergmann F, Strobel O, et al. Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg. 2011;254:311\u20139.","journal-title":"Ann Surg."},{"key":"9467_CR27","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/bjs.10832","volume":"105","author":"N Ironside","year":"2018","unstructured":"Ironside N, Barreto SG, Loveday B, et al. Meta-analysis of an artery-first approach versus standard pancreatoduodenectomy on perioperative outcomes and survival. Br J Surg. 2018;105:628\u201336.","journal-title":"Br J Surg."},{"key":"9467_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ctrv.2014.11.002","volume":"41","author":"C Verbeke","year":"2015","unstructured":"Verbeke C, Lohr M, Severin Karlsson J, Del Chiaro M. Pathology reporting of pancreatic cancer following neoadjuvant therapy: challenges and uncertainties. Cancer Treat Rev. 2015;41:17\u201326.","journal-title":"Cancer Treat Rev."},{"key":"9467_CR29","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1001\/jamasurg.2016.1113","volume":"151","author":"S Tsai","year":"2016","unstructured":"Tsai S, Evans DB. Therapeutic advances in localized pancreatic cancer. JAMA Surg. 2016;151:862\u20138.","journal-title":"JAMA Surg."},{"key":"9467_CR30","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/bjs.10870","volume":"105","author":"E Versteijne","year":"2018","unstructured":"Versteijne E, Vogel JA, Besselink MG, Busch ORC, Wilmink JW, Daams JG, et al. Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer. Br J Surg. 2018;105:946\u201358.","journal-title":"Br J Surg."},{"key":"9467_CR31","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0140-6736(16)32409-6","volume":"389","author":"JP Neoptolemos","year":"2017","unstructured":"Neoptolemos JP, Palmer DH, Ghaneh P, et al. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet. 2017;389:1011\u201324.","journal-title":"Lancet."},{"key":"9467_CR32","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","volume":"379","author":"T Conroy","year":"2018","unstructured":"Conroy T, Hammel P, Hebbar M, et al. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer. N Engl J Med. 2018;379:2395\u2013406.","journal-title":"N Engl J Med."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09467-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-09467-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09467-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T12:09:24Z","timestamp":1625227764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-09467-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,3]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["9467"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-09467-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,3]]},"assertion":[{"value":"15 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}